Cargando…

762. Real-World Utilization of C. difficile Drug Treatments and Associated Clinical Outcomes in a US Hospital System

BACKGROUND: IDSA recommends use of fidaxomicin or oral vancomycin for treatment of initial episode or first recurrence of Clostridioides difficile infection (CDI). This study aimed to evaluate impact of a clinical decision support order set driving appropriate use of fidaxomicin on utilization of CD...

Descripción completa

Detalles Bibliográficos
Autores principales:	McDaniel, Lauren, Everson, Nathan, White, Melissa, Obi, Engels N, Chen, Yiyun, Kohinke, Rose, Lockhart, Ellen Rachel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644007/ http://dx.doi.org/10.1093/ofid/ofab466.959

Ejemplares similares

Clinical and Economic Outcomes After Implementation of a Fidaxomicin Treatment Optimization and Access Pathway at a US Hospital System
por: McDaniel, Lauren F., et al.
Publicado: (2022)

Correction to: Clinical and Economic Outcomes After Implementation of a Fidaxomicin Treatment Optimization and Access Pathway at a US Hospital System
por: McDaniel, Lauren F., et al.
Publicado: (2022)

2437. First-line Fidaxomicin Use in High-risk Inpatients Reduces Recurrence Rates
por: Kohinke, Rose, et al.
Publicado: (2019)

757. Evaluating Use of the New ICD-10 Codes for Clostridioides difficile Infection in the Premier U.S. Hospital Discharge Database
por: Deshpande, Abhishek, et al.
Publicado: (2021)

15. Real-World Changes in Clostridioides difficile infection (CDI) Treatment Utilization and Clinical Outcomes Associated with Updated 2017 IDSA Guidelines among Medicare Beneficiaries in the U.S
por: Dubberke, Erik R, et al.
Publicado: (2021)

917. Infectious Diseases Consult Improves Management of Candidemia
por: Stornelli, Nick, et al.
Publicado: (2022)

Adoption and Trends in Uptake of Updated ICD-10 Codes for Clostridioides difficile—A Retrospective Observational Study
por: Deshpande, Abhishek, et al.
Publicado: (2022)

762. Sex Differences in the Epidemiology of Tuberculosis in Tunisia
por: Jemaa, Maissa Ben, et al.
Publicado: (2018)

Exam Ref 70-762 Developing SQL Databases
por: Davidson, Louis
Publicado: (2017)

Variability in antifungal utilization among neonatal, pediatric, and adult inpatients in academic medical centers throughout the United States of America
por: Stultz, Jeremy S., et al.
Publicado: (2018)

Antiemetic Prescription Fills in Pregnancy: A Drug Utilization Study Among 762,437 Pregnancies in Norway
por: van Gelder, Marleen M H J, et al.
Publicado: (2021)

787. Evaluation of Clostridioides difficile Environmental Contamination Surrounding C. difficile Patients vs. non-C. difficile Patients in Outpatient Infusion Centers
por: Garey, Kevin W, et al.
Publicado: (2020)

miR-762 can negatively regulate menin in ovarian cancer
por: Hou, Rui, et al.
Publicado: (2017)

Complete genome sequence of Pedobacter heparinus type strain (HIM 762-3(T))
por: Han, Cliff, et al.
Publicado: (2009)

PARP-1 Val762Ala Polymorphism Is Associated with Risk of Cervical Carcinoma
por: Ye, Feng, et al.
Publicado: (2012)

762 Resumption of Surgical Missions in Light of COVID-19: A Paradigm Shift
por: Dabek, Robert J, et al.
Publicado: (2022)

Causes of thrombocytopenia in dogs in the United Kingdom: A retrospective study of 762 cases
por: Martín‐Ambrosio Francés, Marina, et al.
Publicado: (2023)

Correction to: Budget Impact Analysis of Fidaxomicin Versus Vancomycin for the Treatment of Clostridioides difficile Infection in the United States
por: Jiang, Yiling, et al.
Publicado: (2022)

Health care resource utilization and costs of recurrent Clostridioides difficile infection in the elderly: a real-world claims analysis
por: Nelson, Winnie W, et al.
Publicado: (2021)

Mitochondrial miR-762 regulates apoptosis and myocardial infarction by impairing ND2
por: Yan, Kaowen, et al.
Publicado: (2019)

762. Climate Change and the Seroprevalence of Borrelia burgdorferi over 25 Years in Rhode Island
por: Espich, Scott, et al.
Publicado: (2020)

762 A Systematic Review of Surgical Simulation in Burn Surgery: Education, Assessment, and Management
por: Roohani, Idean, et al.
Publicado: (2023)

Real-World Experience with Bezlotoxumab for Prevention of Recurrence of Clostridioides difficile Infection
por: Escudero-Sánchez, Rosa, et al.
Publicado: (2020)

Real-world utilization patterns of systemic immunosuppressants among US adult patients with atopic dermatitis
por: Armstrong, April W., et al.
Publicado: (2019)

Involvement of PARP-1 Val762Ala Polymorphism in the Onset of Cervical Cancer in Caucasian Women
por: Roszak, Andrzej, et al.
Publicado: (2013)

Utilization Trends and Impact of Secukinumab Treatment on Clinical Outcomes in Biologic-Naive Patients with Psoriasis in a US Real-World Setting
por: Strober, Bruce, et al.
Publicado: (2022)

Real-world Experience of Bezlotoxumab for Prevention of Clostridioides difficile Infection: A Retrospective Multicenter Cohort Study
por: Hengel, Richard L, et al.
Publicado: (2020)

798. Metronidazole Exposure Prior to Clostridiodes difficile Infection (CDI) is a Risk Factor for Severe C. difficile Disease in Cancer Patients
por: Francisco, Denise Marie A, et al.
Publicado: (2020)

Association between PARP-1 V762A Polymorphism and Breast Cancer Susceptibility in Saudi Population
por: Alanazi, Mohammad, et al.
Publicado: (2013)

miR-762 activation confers acquired resistance to gefitinib in non-small cell lung cancer
por: Ge, Peng, et al.
Publicado: (2019)

The Utility of Euroflow MRD Assessment in Real-World Multiple Myeloma Practice
por: Turner, Rose, et al.
Publicado: (2022)

729. Real World Efficacy of Bezlotoxumab for Prevention of Clostridioides Difficile Recurrence in Immunosuppressed Patients
por: Perreault, Sarah, et al.
Publicado: (2020)

Real-world Use of Bezlotoxumab and Fecal Microbiota Transplantation for the Treatment of Clostridioides difficile Infection
por: de la Villa, Sofía, et al.
Publicado: (2023)

Impact of Updated Clinical Practice Guidelines on Outpatient Treatment for Clostridioides difficile Infection and Associated Clinical Outcomes
por: Dubberke, Erik R, et al.
Publicado: (2022)

Recurrent Clostridioides difficile infection worsens anxiety-related patient-reported quality of life
por: Hengel, Richard L., et al.
Publicado: (2022)

S107. HEALTHCARE UTILIZATION AND COST IN SCHIZOPHRENIA AND BIPOLAR DISORDER: REAL-WORLD EVIDENCE FROM US CLAIMS DATABASES
por: Greene, Mallik, et al.
Publicado: (2018)

Real-World Health Care Resource Utilization and Costs Among US Patients with Knee Osteoarthritis Compared with Controls
por: Bedenbaugh, Angela V, et al.
Publicado: (2021)

678. Changes in the Clostridioides difficile Infection (CDI) Treatment Pattern Pre-Post Clinical Guideline Update in 2021 and Variations across Hospitals
por: Dubberke, Erik R, et al.
Publicado: (2023)

PARP-1 Val762Ala polymorphism is associated with reduced risk of non-Hodgkin lymphoma in Korean males
por: Jin, Xue Mei, et al.
Publicado: (2010)

Correction: Association between PARP-1 V762A Polymorphism and Breast Cancer Susceptibility in Saudi Population
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_c8h3749gplanns7l4n45pgsr39